Advanced Non-small Cell Lung Cancer With KRAS G12C Mutation

Explore clinical trials studying Advanced Non-small Cell Lung Cancer With KRAS G12C Mutation. Study availability and eligibility vary by location and protocol.

1 public trial 1 recruiting study

Refine in advanced search Browse all conditions

Advanced Non-small Cell Lung Cancer With KRAS G12C Mutation trial results

Recruiting

Ladarixin With Sotorasib in Advanced NSCLC

NCT05815173

Conditions: Advanced Non-small Cell Lung Cancer With KRAS G12C Mutation
Locations: NYU Langone Health Garden City, New York, United States

NYU Langone Health Mineola, New York, United States

NYU Langone Health New Hyde Park, New York, United States

NYU Langone Health New York, United States

View Trial Details